Why the study?
Does ivabradine improve left ventricular function and modulate the RAAS in a rat model of L-NAME-induced hypertension?
Does ivabradine improve left ventricular function and modulate the RAAS in a rat model of L-NAME-induced hypertension?
In a rat model of L-NAME-induced hypertension, ivabradine improved left ventricular function and reduced aldosterone levels, suggesting a protective effect on the hypertensive heart.
Answers are grounded in this paper and cite their sources.
Animal data on ivabradine are hypothesis-generating; human trials needed before any clinical consideration in hypertension.
Ivabradine, the selective inhibitor of the If current in the sinoatrial node, exerts cardiovascular protection by its bradycardic effect and potentially pleiotropic actions. However, there is a shortage of data regarding ivabradine’s interaction with the renin-angiotensin-aldosterone system (RAAS). This study investigated whether ivabradine is able to protect a hypertensive heart in the model of L-NAME-induced hypertension and to interfere with the RAAS. Four groups (n = 10/group) of adult male Wistar rats were treated as follows for four weeks: control, ivabradine (10 mg/kg/day), L-NAME (40 mg/kg/day), and L-NAME plus ivabradine. L-NAME administration increased systolic blood pressure (SBP) and left ventricular (LV) weight, enhanced hydroxyproline concentration in the LV, and deteriorated the systolic and diastolic LV function. Ivabradine reduced heart rate (HR) and SBP, and improved the LV function. The serum concentrations of angiotensin Ang 1–8 (Ang II), Ang 1–5, Ang 1–7, Ang 1–10, Ang 2–8, and Ang 3–8 were decreased in the L-NAME group and ivabradine did not modify them. The serum concentration of aldosterone and the aldosterone/Ang II ratio were enhanced by L-NAME and ivabradine reduced these changes. We conclude that ivabradine improved the LV function of the hypertensive heart in L-NAME-induced hypertension. The protective effect of ivabradine might have been associated with the reduction of the aldosterone level.
No takes yet. Share an insight, caveat, or question.
Šimko et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: